You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stopping oral antiviral therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stopping Antiviral Treatment in Chronic Hepatitis B

Recruiting
  • Chronic Hepatitis b
  • Hong Kong, Please Select One ..., Hong Kong
    Man Fung Yuen
Sep 28, 2021

After Long-Term Antiviral Treatment for Chronic Hepatitis B

Completed
  • Chronic Hepatitis B e Antigen Positive
  • Chronic Hepatitis B e Antigen Negative
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Chronic Hepatitis B Trial in Seoul (Standard of care)

    Active, not recruiting
    • Chronic Hepatitis B
    • Standard of care
    • Seoul, Korea, Republic of
    • +3 more
    Mar 29, 2023

    Hepatitis B, Chronic Trial in Gothenburg (Stopping)

    Not yet recruiting
    • Hepatitis B, Chronic
    • Stopping
    • Gothenburg, VGR, Sweden
      Infectious Diseases Clinic, Sahlgrenska University Hospital
    Apr 13, 2022

    Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)

    Not yet recruiting
    • Chronic Hepatitis b
    • STSG-0002 Injection
    • Beijing, Beijing, China
    • +3 more
    Mar 6, 2023

    Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)

    Not yet recruiting
    • Chronic Hepatitis b
    • STSG-0002 Injection
    • Beijing, Beijing, China
    • +3 more
    Mar 6, 2023

    Hiv, Hormone Therapy Trial in San Diego (Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg, Emtricitabine Tenofovir

    Completed
    • Hiv
    • Hormone Therapy
    • Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg
    • Emtricitabine Tenofovir Alafenamide 200/25 mg
    • San Diego, California
      UC San Diego AntiViral Research Center (AVRC)
    Sep 21, 2022

    Corona Virus Infection, Middle East Respiratory Syndrome (MERS), Acute Respiratory Distress Syndrome Trial in Cairo (Lactoferrin

    Not yet recruiting
    • Corona Virus Infection
    • +5 more
    • Lactoferrin (Apolactoferrin)
    • Placebo of excipient(s) will be administered
    • Cairo, Giza, Egypt
    • +3 more
    Nov 12, 2021

    Antiviral Therapy for Patients With Liver Cancer After Surgery

    Recruiting
    • Hepatocellular Carcinoma
      • Changsha, Hunan, China
        Xiangya Hospital of Central South University
      Jul 19, 2022

      HCV-TARGET- Hepatitis C Therapeutic Registry and Research

      Active, not recruiting
      • Hepatitis C
        • Phoenix, Arizona
        • +59 more
        Oct 5, 2022

        Chronic Hepatitis B Trial in Daegu (Experimental)

        Completed
        • Chronic Hepatitis B
        • Daegu, Korea, Republic of
          Daegu Chatholic University Medical center
        Jul 26, 2021

        Hepatitis B, Chronic Trial in Worldwide (administration of SLGN in arm C, Discontinuation of NUC treatment in arms B and C)

        Recruiting
        • Hepatitis B, Chronic
        • administration of SLGN in arm C
        • Discontinuation of NUC treatment in arms B and C
        • Lyon, France
        • +7 more
        Mar 11, 2022

        Metabolic Syndrome on Antiviral Response in People With Chronic

        Not yet recruiting
        • Chronic Hepatitis b
          • (no location specified)
          Jan 21, 2023

          HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)

          Recruiting
          • HIV-1-infection
          • Kisumu, Kenya
          • +6 more
          Feb 1, 2023

          Nirmatrelvir-ritonavir in Hospitalized Patients

          Recruiting
          • Hospitalized Patients
          • Hangzhou, Zhejiang, China
            Changcheng Shi
          Feb 26, 2023

          Hepatitis B, Chronic Trial in Worldwide (Stop of therapy)

          Active, not recruiting
          • Hepatitis B, Chronic
          • Stop of therapy
          • København, Denmark
          • +10 more
          Sep 13, 2021

          HIV, Cytomegalovirus, CMV Trial in United States (Letermovir 240 MG Oral Tablet, Letermovir 480 MG Oral Tablet, Combination ART)

          Recruiting
          • HIV Infections
          • +2 more
          • Letermovir 240 MG Oral Tablet
          • +2 more
          • Birmingham, Alabama
          • +18 more
          Jun 20, 2022

          Chronic Hepatitis b Trial in Taiwan (Nuc Discontinuation, Entecavir or Tenofovir)

          Active, not recruiting
          • Chronic Hepatitis b
          • Nuc Discontinuation
          • Entecavir or Tenofovir
          • Chiayi City, Taiwan
          • +5 more
          Mar 30, 2023

          Cytomegalovirus Anterior Uveitis Trial in San Francisco (Valganciclovir Hydrochloride, Ganciclovir Sodium, Placebo Oral Tablet)

          Recruiting
          • Cytomegalovirus Anterior Uveitis
          • Valganciclovir Hydrochloride
          • +3 more
          • San Francisco, California
            Proctor Foundation, UCSF
          Jul 1, 2022

          Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)

          Recruiting
          • Hepatitis B
          • HIV Infections
          • San Diego, California
          • +35 more
          Jan 31, 2023

          HIV Trial in Puerto Rico, United States (Standard of Care (SOC) Oral ART, Oral RPV, Oral CAB)

          Recruiting
          • HIV Infections
          • Standard of Care (SOC) Oral ART
          • +6 more
          • Birmingham, Alabama
          • +34 more
          Dec 1, 2021

          SARS-CoV-2 Infection Trial in Washington (Coronavirus-specific T cell (CST))

          Recruiting
          • SARS-CoV-2 Infection
          • Coronavirus-specific T cell (CST)
          • Washington, District of Columbia
          • +1 more
          Sep 1, 2022

          Treatment Optimization of Refractory

          Recruiting
          • Hepatitis B, Chronic
          • Virus Diseases
          • original therapy
          • rescue therapy
          • Ankang, China
          • +12 more
          Feb 1, 2023

          COVID-19 Trial in India (Brequinar Sodium, Dipyridamole 75 MG, Placebo)

          Terminated
          • COVID-19
          • Brequinar Sodium
          • +2 more
          • Srikakulam, Andhra Pradesh, India
          • +6 more
          Jun 16, 2022

          Haematological Malignancy, Hypogammaglobulinemia Trial (trimethoprim-sulfamethoxazole (co-trimoxazole), amoxycillin/clavulanic

          Not yet recruiting
          • Haematological Malignancy
          • Hypogammaglobulinemia
          • trimethoprim-sulfamethoxazole (co-trimoxazole)
          • +2 more
          • (no location specified)
          Jan 4, 2023